Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Vitiligo causes white skin patches and can lead to psychological stress.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Topical sensitizers have mixed success in treating alopecia areata.

Many research paper titles in dermatology journals lack scientific precision.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Using one's own blood platelets and fat can improve facial and hair appearance without surgery.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Immune cells are essential for early hair and skin development and healing.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

New technologies show potential for better understanding and treating skin conditions with abnormal mucin, but more research is needed for clinical use.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

People with alopecia areata have much lower Vitamin-D levels than healthy individuals.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.